ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2018 American Transplant Congress

    Recipient HO-1 Deficiency Decreases Post-Transplant Graft HO-1 Expression and Exacerbates Liver Transplant Damage

    S. Kageyama,1 K. Nakamura,1 T. Ito,1 A. Aziz,1 B. Ke,1 R. Sossa,2 E. Reed,2 F. Kaldas,1 R. Busuttil,1 J. Kupiec-Weglinski.1

    1Surgery, Liver Transplantation, UCLA, Los Angeles, CA; 2Pathology, UCLA, Los Angeles, CA.

    Many preclinical studies on protective functions of heme oxygenase-1 (HO-1; hsp32) in orthotopic liver transplantation (OLT) have encouraged application of HO-1 inducing regimens in clinical…
  • 2018 American Transplant Congress

    Direct-Acting Antiviral Therapy Immune-Mediated Graft Dysfunction in Liver Transplant Recipients with Hepatitis C

    C. Chan,1 E. Agudelo,2 J. Haydek,3 M. Hoteit,4 M. Laurito,5 J. Norvell,3 T. Schiano,6 N. Terrault,2 E. Verna,5 A. Yang,1 J. Levitsky.1

    1Northwestern University, Chicago, IL; 2UCSF, San Francisco, CA; 3Emory University, Atl, GA; 4University of Pennsylvania, Philadelphia, PA; 5Columbia University, NY, NY; 6Mount Sinai, NY, NY.

    Background and Aims:Interferon (IFN) treatment of hepatitis C virus (HCV) infection after liver transplantation (LT) can result in severe immune-mediated graft dysfunction (IGD). The occurrence…
  • 2018 American Transplant Congress

    Medication Adherence: Does Where You Live Matter?

    S. Wadhwani,1 S. Taylor,1 C. Brokamp,1 W. Guo,1 E. Shemesh,2 J. Bucuvalas.1

    1Cincinnati Children's Hospital Medical Center, Cincinnati; 2Mount Sinai School of Medicine, New York.

    Background & Objectives: Medication non-adherence remains problematic in pediatric liver transplant (LT)[mdash]estimates suggest that up to 53% of adolescents are non-adherent. We leveraged data from…
  • 2018 American Transplant Congress

    Long-Term Medical, Financial, Psychosocial, and Overall Health-Related Quality of Life after Living Donation in Liver Transplantation

    J. Emamaullee,1 L. Sher,1 T-.L. Fong,2 K. Dhanireddy,1 S. Zielsdorf,1 C. Romero,1 N. Wade,1 Y. Genyk.1

    1Surgery, University of Southern California, Los Angeles, CA; 2Keck School of Medicine at the University of Southern California, Los Angeles, CA.

    Background: The long-term impact of living donation (LD) in liver transplantation on health-related quality of life (HRQOL) has not been well characterized. This study was…
  • 2018 American Transplant Congress

    CCAAT-Enhancer-Binding Protein Homologous Protein Promotes Liver Ischemia and Reperfusion Injury by Inhibiting Beclin-1-Mediated Autophagy in Hepatocytes

    H. Zhou,1 Z. Rao,1 Y. Xia,1 R. Liu,1 S. Zhou,1 X. Wang,1 Y. Zhai,1 L. Lu.1

    1First Affiliated Hospital of Nanjing Medical University, Nanjing, China; 2David Geffen School of Medicine at University of California-Los Angeles, Los Angeles.

    Background and Aims:Critical role of endoplasmic reticulum (ER) stress has been found in ischemia and reperfusion(IR) injury models. However, the role of CCAAT-Enhancer-Binding Protein Homologous…
  • 2018 American Transplant Congress

    Does Biliary Duct Reconstruction Technique Impact Liver Transplantation Outcomes?

    R. Shahbazov,1 M. Kessel,2 K. Knapp,2 F. Azari,2 S. Tsutsui,3 A. Nickkholgh,1 D. Maluf,1 S. Pelletier.1

    1Surgery, University of Virginia Health System, Charlottesville, VA; 2School of Medicine, University of Virginia Health System, Charlottesville, VA; 3Surgery, University of Pennsylvania, Philadelphia, PA.

    Introduction: The rate of biliary complication after liver transplantation remains high. The choice of biliary reconstruction technique may depend on the patient's primary disease, possible…
  • 2018 American Transplant Congress

    Waitlist Candidates Who Travel for Liver Transplantation and the Donor Organs They Receive

    J. Ge, J. Lai.

    Medicine, UCSF, San Francisco, CA; Medicine, UCSF, San Francisco, CA.

    Background:Geographic disparities in access to liver transplantation (LT) has led to candidates seeking LT outside their home UNOS region (“Travelers”). Little is known about their…
  • 2018 American Transplant Congress

    Reduction in Circulating CD19+CD24+CD27+ Regulatory B Cell Frequency Predicts Acute Rejection in Liver Transplant Patients

    H. Zhou, Z. Rao, Y. Lu, J. Rao, J. Gu, L. Lu, Y. Xia.

    Liver Transplant Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

    Background: Accumulating evidence suggests that regulatory B cells (Bregs) play an important role in modulating inflammation and autoimmune diseases. However, whether Bregs regulate acute liver…
  • 2018 American Transplant Congress

    A Long-Term Experience with Expansion of Milan Criteria for Liver Transplant Recipients

    S. Commander,1 B. Shaw,1 L. Washburn,2 D. Yoeli,2 A. Rana,2 J. Goss.2

    1Duke University, Durham, NC; 2Baylor College of Medicine, Houston, TX.

    Background: The Milan Criteria (MC) have historically determined eligibility for transplantation for hepatocellular carcinoma (HCC). The United Network for Organ Sharing (UNOS) Region 4 expanded…
  • 2018 American Transplant Congress

    De Novo Use of Extended Released Tacrolimus (Meltdose, EnvasusR)) after OLT – Does the Colonic Resorption Influences the Outcome?

    T. Soliman, G. Györi, M. Hofmann, A. Salat, S. Rockenschaub, G. Berlakovich.

    Department of Transplantation, Medical University of Vienna, Vienna, Austria.

    Introduction: Immunosuppression after OLT has reached a quite high standard with an excellent evidence base. However, there is still a lack of data for the…
  • « Previous Page
  • 1
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences